Effects of dietary caffeine on mood when rested and sleep restricted

Human Psychopharmacology

Volumn 19, Issue 5, 2004, Pages 333-341

  James, Jack E ^a   Gregg, M ELizabeth ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Caffeine; Mood; Physical dependence; Sleep restriction; Withdrawal relief

Indexed keywords

CAFFEINE; PLACEBO;

ABSTINENCE; ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIETARY INTAKE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; FEMALE; FOOD INTAKE; GENDER; HUMAN; MALE; MOOD DISORDER; PRIORITY JOURNAL; REST; SALIVA LEVEL; SCORING SYSTEM; SLEEP TIME; VOLUNTEER;

ADOLESCENT; ADULT; AFFECT; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DIET; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; REST; SALIVA; SLEEP DEPRIVATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 4243202907     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.589     Document Type: Article

References (44)

1. Abernethy DR, Todd EL. 1985. Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives. Eur J Clin Pharmacol 28: 425-428.
2. Alkaysi HN, Shiekh Salem M, El-Sayed YM. 1988. High performance liquid chromatographic analysis of caffeine concentrations in plasma and saliva. J Clin Pharm Ther 13: 109-115.
3. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders-Text Revision (4th edn). APA: Washington, DC.
4. Azcona O, Barbanoj MJ, Torrent J, Jané F. 1995. Evaluation of the central effects of alcohol and caffeine interaction. Br J Clin Pharmacol 40: 393-400.
5. Bonnet MH, Arand DL. 1994a. Impact of naps and caffeine on extended nocturnal performance. Physiol Behav 56: 103-109.
6. Bonnet MH, Arand DL. 1994b. The use of prophylactic naps and caffeine to maintain performance during a continuous operation. Ergon 37: 1009-1020.
7. Denaro, C, Brown CR, Jacob P III, Berowitz NL. 1991. Effects of caffeine with repeated dosing. Eur J Clin Pharmacol 403: 273-278.
8. Evans SM, Griffiths RR. 1991. Dose-related caffeine discrimination in normal volunteers: individual differences in subjective effects and self-reported cues. Behavioral Pharmacol 2: 345-356.
9. Goldstein A, Kaizer S, Whitby O. 1969. Psychotropic effects of caffeine in man - IV. quantitative and qualitative differences associated with habituation to coffee. Clin Pharmacol Ther 10: 489-497.
10. Griffiths RR, Bigelow GE, Liebson IA, O'Keeffe M, O'Leary D, Russ N. 1986. Human coffee drinking: manipulation of concentration and caffeine dose. J Exp Anal Behav 45: 133-148.
11. Griffiths RR, Evans SM, Heishman SJ, et al. 1990. Low-dose caffeine physical dependence in humans. J Pharmacol Exp Ther 255: 1123-1132.
12. Griffiths RR, Woodson PP. 1988. Reinforcing effects of caffeine in humans. J Pharmacol Exp Ther 246: 21-29.
13. Horne JA, Reyner LA. 1996. Counteracting driver sleepiness: effects of napping, caffeine, and placebo. Psychophysiology 33: 306-309.
14. Horne JA, Reyner LA. 2001. Beneficial effects of an 'energy drink' given to sleepy drivers. Amino Acids 20: 83-89.
15. Hughes JR, Oliveto AH, Bickel WK, Higgins ST, Badger GJ. 1993. Caffeine self-administration and withdrawal: incidence, individual differences and interrelationships. Drug Alcohol Depend 32: 239-246.
16. James JE. 1991. Caffeine and Health. Academic Press: London.
17. James JE. 1994a. Does caffeine enhance or merely restore degraded psychomotor performance. Neuropsychobiology 30: 124-125.
18. James JE. 1994b. Psychophysiological effects of habitual caffeine consumption. Int J Behav Med 1: 247-263.
19. James JE. 1995a. Caffeine and psychomotor performance revisited. Neuropsychobiology 31: 202-203.
20. James JE. 1995b. Caffeine, psychomotor performance and commercial interests: reply to Smith [Letter]. Addiction 90: 1262-1265.
21. James JE. 1997. Understanding Caffeine: A Biobehavioral Analysis. Sage Publications: Thousand Oaks, CA.
22. James JE. 1998. Acute and chronic effects of caffeine on performance, mood, headache, and sleep. Neuropsychobiology 38: 32-41.
23. James JE. 2003. Caffeine, mental performance and mood. In Performance Functional Foods, Watson D (ed.). Woodhead Publishing: London; 168-194.
24. James JE, Bruce MS, Lader MH, Scott NR. 1989. Self-report reliability and symptomatology of habitual caffeine consumption. Br J Clin Pharmacol 27: 507-514.
25. Lane JD, Phillips-Bute BG. 1998. Caffeine deprivation affects vigilance performance and mood. Physiol Behav 65: 171-175.
26. Lelo A, Miners JO, Robson R, Birkett DJ. 1986. Assessment of caffeine exposure: caffeine content of beverages caffeine intake and plasma concentrations of methylxanthines. Clin Pharmacol Ther 39: 54-59.
27. Lieberman HR, Wurtman RJ, Emde GG, Roberts C, Coviella ILG. 1987. The effects of low doses of caffeine on human performance and mood. Psychopharmacology 92: 308-312.
28. McNair PM, Lorr M, Droppleman LF. 1981. Profile of Mood States Manual. Educational and Industrial Testing Service: San Diego, CA.
29. McNair PM, Lorr M, Droppleman LF. 1988. Profile of Mood States: Bipolar Form. Educational and Industrial Testing Service: San Diego, CA.
30. Parsons WD, Neims MD. 1978. Effect of smoking on caffeine clearance. Clin Pharmacol Ther 24: 40-45.
31. Pfeifer RW, Notari RE. 1988. Predicting caffeine plasma concentrations resulting from consumption of food or beverages: a simple method and its origin. Drug Intel Clin Pharm 22: 953-959.
32. Phillips-Bute BG, Lane JD. 1998. Caffeine withdrawal symptoms following brief caffeine deprivation. Physiol Behav 63: 35-39.
33. Rall TW. 1990. Drugs used in the treatment of asthma. The methylxanthines, cromolyn sodium, and other agents. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, Gilman AG, Rall TW, Nies AS, Taylor P (eds). Pergamon Press: New York; 618-637.
34. Richardson NJ, Rogers PJ, Elliman NA, O'Dell RJ. 1995. Mood and performance effects of caffeine in relation to acute and chronic caffeine deprivation. Pharmacol Biochem Behav 52: 313-320.
35. Robertson D, Wade D, Workman R, Woosley RL, Oates JA. 1981. Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 67: 1111-1117.
36. Silverman K, Griffiths RR. 1992. Low-dose caffeine discrimination and self-reported mood effects in normal volunteers. J Exp Anal Behav 57: 91-107.
37. Smit HJ, Rogers PJ. 2000. Effects of low doses of caffeine on cognitive performance, mood and thirst in low and higher caffeine consumers. Psychopharmacology 152: 167-173.
38. Smith AP. 1995. Caffeine, caffeine withdrawal and psychomotor performance: a reply to James. Neuropsychobiol 31: 200-201.
39. Smith AP, Clark R, Gallagher J. 1999. Breakfast cereal and caffeinated coffee: effects on working memory, attention, mood and cardiovascular function. Physiol Behav 67: 9-17.
40. Smith AP, Maben AL, Brockman P. 1993. The effects of caffeine and evening meals on sleep and performance, mood and cardiovascular functioning the following day. J Psychopharmacology 7: 203-206.
41. Walsh JK, Muelbach MJ, Humm TM, Dickens QS, Sugerman JL. 1990. Effect of caffeine on physiological sleep tendency and ability to sustain wakefulness at night. Psychopharmacology 101: 271-273.
42. Warburton DM. 1995. Effects of caffeine on cognition and mood without caffeine abstinence. Psychopharmacology 119: 66-70.
43. Warburton DM, Bersellini E, Sweeney E. 2001. An evaluation of a caffeinated taurine drink on mood, memory and information processing in healthy volunteers without caffeine abstinence. Psychopharmacology 158: 322-328.
44. Wolfson AR, Carskadon MA, Acebo C, et al. 2003. Evidence for the validity of a sleep habits survey for adolescents. Am Acad Sleep Med 262: 213-216.